These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 10213221)

  • 1. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
    Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials.
    Shalinsky DR; Brekken J; Zou H; McDermott CD; Forsyth P; Edwards D; Margosiak S; Bender S; Truitt G; Wood A; Varki NM; Appelt K
    Ann N Y Acad Sci; 1999 Jun; 878():236-70. PubMed ID: 10415735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.
    Bello L; Lucini V; Carrabba G; Giussani C; Machluf M; Pluderi M; Nikas D; Zhang J; Tomei G; Villani RM; Carroll RS; Bikfalvi A; Black PM
    Cancer Res; 2001 Dec; 61(24):8730-6. PubMed ID: 11751392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
    Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.
    Sathornsumetee S; Hjelmeland AB; Keir ST; McLendon RE; Batt D; Ramsey T; Yusuff N; Rasheed BK; Kieran MW; Laforme A; Bigner DD; Friedman HS; Rich JN
    Cancer Res; 2006 Sep; 66(17):8722-30. PubMed ID: 16951188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
    Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S
    Cancer Res; 1999 Mar; 59(6):1252-8. PubMed ID: 10096556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
    Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Low JA; Johnson MD; Bone EA; Dickson RB
    Clin Cancer Res; 1996 Jul; 2(7):1207-14. PubMed ID: 9816289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
    Lakka SS; Rajan M; Gondi C; Yanamandra N; Chandrasekar N; Jasti SL; Adachi Y; Siddique K; Gujrati M; Olivero W; Dinh DH; Kouraklis G; Kyritsis AP; Rao JS
    Oncogene; 2002 Nov; 21(52):8011-9. PubMed ID: 12439751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor.
    Guan M; Pang CP; Yam HF; Cheung KF; Liu WW; Lu Y
    Cancer Gene Ther; 2004 May; 11(5):325-32. PubMed ID: 15044958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
    Guerin C; Luddy C; Abounader R; Lal B; Laterra J
    Biochem Biophys Res Commun; 2000 Jun; 273(1):287-93. PubMed ID: 10873600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
    Narla RK; Chen CL; Dong Y; Uckun FM
    Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.